FIELD: medicine.
SUBSTANCE: includes: (a) provision of an initial sample of biological fluid from the subject; (b) obtaining of a dynamic light scattering spectrum (DLS) for this sample, that contains peaks corresponding to particles of different sizes that are present in the sample; (c) sample contacting with at least one substance that specifically binds to the immunoglobulins of one or more isotypes contained in the sample; (d) removal of the complexes containing the said substance to obtain a treated sample; (e) obtaining of a DLS spectrum of the treated sample obtained in step (d), which contains peaks corresponding to particles of different sizes that are present in the said treated sample; (e) comparison of the DLS spectrum obtained in step (b) with the spectrum obtained in step (e), based on the differences in the spectrum of the treated sample and the spectrum obtained for the initial sample, the characteristic of isotypic composition of the immune complexes present in the said biological fluid sample is determined. Diagnosis of a disease or condition in a subject based on the determination of the characteristic of the immune complexes isotypic composition in a biological fluid sample obtained from a subject and a kit for this diagnosis are also proposed.
EFFECT: increased diagnostic and predictive informativeness of detection of antigens significant for medical purposes in biological fluids.
35 cl, 5 dwg, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING TUBERCULOSIS IN HEALTHY INDIVIDUALS | 2018 |
|
RU2707571C1 |
ANTIPNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION | 2018 |
|
RU2795769C1 |
BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS | 2017 |
|
RU2759970C2 |
ANTIBODIES AGAINST CCR7 RECEPTOR FOR CANCER TREATMENT | 2006 |
|
RU2404808C2 |
COMPOSITIONS AND METHODS FOR TREATING IMMUNODEFICIENCY | 2015 |
|
RU2724058C2 |
DIAGNOSTIC TECHNIQUE FOR MYCOBACTERIUM TUBERCULOSIS | 2015 |
|
RU2594063C1 |
ANTIBODIES TO THE RELATED CANCER-EMBRYONIC ANTIGEN CELL ADHESION MOLECULE (CEACAM) | 2012 |
|
RU2650869C2 |
COMPOSITIONS AND METHODS OF TREATING CANCER | 2016 |
|
RU2729396C2 |
IDENTIFICATION, ASSESSMENT, AND THERAPY OF CANCERS WITH INNATE OR ACQUIRED RESISTANCE TO ALK INHIBITORS | 2011 |
|
RU2589834C2 |
METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE | 2011 |
|
RU2574976C2 |
Authors
Dates
2017-11-07—Published
2015-11-19—Filed